BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND CDX2, CDX3, 1045, ENSG00000165556, Q99626 AND Treatment
19 results:

  • 1. Patient-reported patterns of follow-up care in the 'Aftercare in Blood Cancer Survivors' (ABC) study.
    Baum J; Lax H; Lehmann N; Merkel-Jens A; Beelen DW; Jöckel KH; Dührsen U
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10531-10542. PubMed ID: 37291404
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Concurrent cdx2 cis-deregulation and UBTF::ATXN7L3 fusion define a novel high-risk subtype of B-cell ALL.
    Passet M; Kim R; Gachet S; Sigaux F; Chaumeil J; Galland A; Sexton T; Quentin S; Hernandez L; Larcher L; Bergugnat H; Ye T; Karasu N; Caye A; Heizmann B; Duluc I; Chevallier P; Rousselot P; Huguet F; Leguay T; Hunault M; Pflumio F; Freund JN; Lobry C; Lhéritier V; Dombret H; Domon-Dell C; Soulier J; Boissel N; Clappier E
    Blood; 2022 Jun; 139(24):3505-3518. PubMed ID: 35316324
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Burden of illness and outcomes in second-line large B-cell lymphoma treatment: real-world analysis of Medicare beneficiaries.
    Kilgore KM; Mohammadi I; Wong AC; Snider JT; Cheng P; Schroeder A; Patel AR
    Future Oncol; 2021 Dec; 17(35):4837-4847. PubMed ID: 34645318
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Expression of Hsa-miR-9 in Children with Acute Lymphoblastic Leukemia and Its Relationship with cdx2 Gene].
    Wang RC; Yang J; Zhang XX; Gao XH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Oct; 28(5):1523-1527. PubMed ID: 33067948
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Comprehensive Geriatric Assessment (CGA): A Simple Tool for Guiding the treatment of Older Adults with Diffuse Large B-Cell lymphoma in China.
    Bai JF; Han HX; Feng R; Li JT; Wang T; Zhang CL; Liu H
    Oncologist; 2020 Aug; 25(8):e1202-e1208. PubMed ID: 32436258
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Clinical characteristics and outcomes of relapsed follicular lymphoma after autologous stem cell transplantation in the rituximab era.
    Sesques P; Bourcier J; Golfier C; Lebras L; Nicolas-Virelizier E; Hacini M; Perrin MC; Voillat L; Bachy E; Traverse-Glehen A; Moreau A; Martin L; Ramla S; Casasnovas O; Le Gouill S; Salles G; Ghesquières H
    Hematol Oncol; 2020 Apr; 38(2):137-145. PubMed ID: 31953963
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Trifluoperazine, an Antipsychotic Drug, Effectively Reduces Drug Resistance in Cisplatin-Resistant Urothelial Carcinoma Cells via Suppressing Bcl-xL: An In Vitro and In Vivo Study.
    Kuo KL; Liu SH; Lin WC; Hsu FS; Chow PM; Chang YW; Yang SP; Shi CS; Hsu CH; Liao SM; Chang HC; Huang KH
    Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31262032
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The clinical significance of cdx2 in leukemia: A new perspective for leukemia research.
    Darvishi M; Mashati P; Khosravi A
    Leuk Res; 2018 Sep; 72():45-51. PubMed ID: 30096576
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Watch-and-wait policy versus rituximab-combined chemotherapy in Japanese patients with intestinal follicular lymphoma.
    Tari A; Kitadai Y; Mouri R; Takigawa H; Asaoku H; Mihara K; Takata K; Fujihara M; Yoshino T; Koga T; Fujimori S; Tanaka S; Chayama K
    J Gastroenterol Hepatol; 2018 Aug; 33(8):1461-1468. PubMed ID: 29377265
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Pathologic classification of "pancreatic cancers": current concepts and challenges.
    Mostafa ME; Erbarut-Seven I; Pehlivanoglu B; Adsay V
    Chin Clin Oncol; 2017 Dec; 6(6):59. PubMed ID: 29307199
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Risk factors and a prognostic score for survival after autologous stem-cell transplantation for relapsed or refractory Hodgkin lymphoma.
    Bröckelmann PJ; Müller H; Casasnovas O; Hutchings M; von Tresckow B; Jürgens M; McCall SJ; Morschhauser F; Fuchs M; Borchmann P; Moskowitz CH; Engert A
    Ann Oncol; 2017 Jun; 28(6):1352-1358. PubMed ID: 28327958
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Expression of Sirt1 and FoxP3 in classical Hodgkin lymphoma and tumor infiltrating lymphocytes: Implications for immune dysregulation, prognosis and potential therapeutic targeting.
    Quesada AE; Assylbekova B; Jabcuga CE; Zhang R; Covinsky M; Rios A; Nguyen ND; Brown RE
    Int J Clin Exp Pathol; 2015; 8(10):13241-8. PubMed ID: 26722524
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Aberrant expression of the homeobox gene cdx2 in pediatric acute lymphoblastic leukemia.
    Riedt T; Ebinger M; Salih HR; Tomiuk J; Handgretinger R; Kanz L; Grünebach F; Lengerke C
    Blood; 2009 Apr; 113(17):4049-51. PubMed ID: 19218548
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Copy number alterations in childhood acute lymphoblastic leukemia and their association with minimal residual disease.
    Steinemann D; Cario G; Stanulla M; Karawajew L; Tauscher M; Weigmann A; Göhring G; Ludwig WD; Harbott J; Radlwimmer B; Bartram C; Lichter P; Schrappe M; Schlegelberger B
    Genes Chromosomes Cancer; 2008 Jun; 47(6):471-80. PubMed ID: 18311775
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Activity of rituximab plus cyclophosphamide, doxorubicin/mitoxantrone, vincristine and prednisone in patients with relapsed MALT lymphoma.
    Raderer M; Wohrer S; Streubel B; Drach J; Jager U; Turetschek K; Troch M; Puspok A; Zielinski CC; Chott A
    Oncology; 2006; 70(6):411-7. PubMed ID: 17220639
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Prognostic analysis of 62 cases of nasal NK/T-cell lymphoma].
    Xiao J; Wang SS; Huang Y; Chen LK; Guan ZZ; Huang HQ; Xia ZJ; Xu RH; Lin TY
    Ai Zheng; 2006 Sep; 25(9):1173-7. PubMed ID: 16965665
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Intensive chemotherapy in the treatment of aggressive diffuse large B-cell lymphoma: malignant lymphoma.
    Avilés A; Nambo MJ; Neri N; Talavera A; Castañeda C; Murillo E; Cleto S; Huerta-Guzmán J
    Med Oncol; 2004; 21(3):269-72. PubMed ID: 15456955
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Humanized anti-CD20 monoclonal antibody (Rituximab) treatment for post-transplant lymphoproliferative disorder.
    Ganne V; Siddiqi N; Kamaplath B; Chang CC; Cohen EP; Bresnahan BA; Hariharan S
    Clin Transplant; 2003 Oct; 17(5):417-22. PubMed ID: 14703923
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Acute nonlymphocytic leukemia: onset after treatment for Hodgkin's disease.
    Maurizi Enrici R; Anselmo AP; Osti MF; Santoro M; Sbarbati S; Tombolini V; Mandelli F; D'Arcangelo E; Biagini C
    Ann Hematol; 1997 Mar; 74(3):103-10. PubMed ID: 9111422
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.